LUPIN Q4
Hot stocks: Brokerage take on L&T Finance, Bajaj Finance, Gujarat Gas, Sun Pharma, and others Brokerage firms such as UBS have maintained a buy rating on L&T Finance, while JP Morgan maintained an overweight rating on Bajaj Finance, Citi has initiated coverage on Indegene and maintained a sell rating on Gujarat Gas.
04 Jul, 2024, 09.02 AM ISTLupin share price drops 5% post Q4 earnings Lupin Share Price: Its revenue from operations in the same period jumped 12% YoY to Rs 4,961 crore as against Rs 4430 crore in the corresponding period of last year.
07 May, 2024, 01.06 PM ISTHot Stocks: Brokerage view on Lupin and Gujarat Gas; Marico gets an upgrade Investec raised Marico's rating from hold to buy, while Jefferies upheld a buy rating for Godrej Consumer. JPMorgan continued to rate Gujarat Gas as underweight and maintained a neutral stance on Lupin.
07 May, 2024, 09.44 AM IST- ADVERTISEMENT
Lupin Q4 Results: Profit jumps 52% YoY to Rs 368 crore; revenue up 12% Lupin reported a 52% YoY growth in net profit to Rs 368 crore for March 2024 quarter. Revenue increased by 12% to Rs 4,961 crore. The company declared a dividend of Rs 8 per share.
06 May, 2024, 09.17 PM ISTQ4 results this week: SBI, Tata Motors, L&T, Asian Paints, TVS Motor and PB Fintech Various widely tracked companies like Tata Motors, SBI, Asian Paints, BPCL, Larsen & Toubro, Tata Power, Canara Bank, TVS Motor, Hero MotoCorp, Godrej Consumer Products, JSW Energy, Dr. Reddy's Laboratories, PB Fintech, and Bank of Baroda will be re...
05 May, 2024, 10.39 AM ISTQ4 results preview: 29 companies likely to report doubling of profit 29 companies expected to double profits in Q4FY24 across various sectors like BFSI, Auto, Healthcare. Notable companies include Adani Ports, KEC International, Birla Corporation, JK Cements, United Breweries, Gland Pharma, Quess Corp Ltd, Signature ...
16 Apr, 2024, 11.15 AM ISTForam Parekh on what to bet on in pharma pack Foram Parekh shares insights on CDMO companies' positive outlook post-Covid correction, potential impact of Biosecure Law, concerns about Laurus's earnings improvement, Sun Pharma's specialty sales focus, and recommendations for pharma sector growth...
12 Apr, 2024, 03.31 PM ISTHot Stocks: Brokerage view on Page Industries, Zomato, Lupin and ITC Macquarie maintained an underperform rating on Zomato with a target price of Rs 76. The company has seen steady margin improvements and strong Quick Commerce growth, it said.
09 Feb, 2024, 09.53 AM ISTLupin Q3 Results: Net profit triples to Rs 619 crore on sales growth The company reported a net profit of Rs 158 crore in the corresponding quarter of the previous year. Revenue from operations grew 20.2% YoY to Rs 5197 crore in Q3FY24.
07 Feb, 2024, 09.17 PM ISTQ3 results today: Nestle, Tata Consumer, Trent among 190 companies to announce earnings On Tuesday, Nearly 160 companies will be announcing their December quarter earnings including the likes of Britannia Industries and FSN E-Commerce Ventures which operates Nykaa brand.
07 Feb, 2024, 09.45 AM ISTPharma, not IT a proxy against weak dollar now; 4 stocks to play: Sanjiv Bhasin Sanjiv Bhasin says: “There is enough room for ICICI Bank now to go to new highs. Do not play it for the next few days. This is one stock which should be in your portfolio for that 20% upside which will take it to that $100 billion club. This will be...
05 Jan, 2024, 11.15 AM ISTHot Stocks: Brokerage view on Lupin, Godrej Consumer, Aarti Industries and Bata India Morgan Stanley maintained an overweight rating on Aarti Industries with a target price of Rs 575. Agrochemicals make up one-third of Aarti's revenue.
28 Dec, 2023, 09.00 AM ISTQ2 results season kicks off this week. 32 companies may report over 100% profit growth Domestic cyclicals like banks, auto and capital goods are likely to lead earnings growth while healthcare and technology may clock a moderate earnings growth. Motilal Oswal sees Nifty earnings growing by 21% YoY in Q2 while Kotak Equities has predic...
10 Oct, 2023, 11.13 AM ISTWhat triggered Lupin’s growth spurt & can it be sustained? "From Q2 onwards, we expected to get back to double digit growth and are very happy that it is happening in Q1 itself. The growth year on year was 10.2%. In fact, if we take out the Cidmus 50 effect from the base and adjust for price impact, the gro...
04 Aug, 2023, 02.00 PM ISTLupin shares fall over 4%. Should you buy, sell or hold? Here's what brokerages say Lupin witnessed a fall of over 4% to Rs 838.1 in intra-day trade on BSE after brokerages such as Jefferies, Kotak, and Bernstein maintained a reduce, underperform, and market-perform rating, respectively, on the stock. Jefferies found the gSpiriva a...
22 Jun, 2023, 12.49 PM ISTLupin shares hit 52-week high after launch of HIV drug Darunavir in US Lupin's shares reached a 52-week high of INR 830.3 after it announced the launch of its Darunavir Tablets to market a generic equivalent of Janssen Products' Prezista Tablets. The estimated annual sales of Darunavir Tablets in the US is at around $3...
06 Jun, 2023, 10.53 AM ISTQ4 results today: What to expect from Lupin, Apollo Tyres and Westlife Foodworld Lupin, Apollo Tyres, Westlife, Raymond and Nazara are set to release their Q4 results on Tuesday. Lupin is expected to report a profit of Rs 233 crore, down from the last quarter but considerably better than the loss of Rs 518 crore reported last ye...
09 May, 2023, 10.01 AM ISTQ4 results this week: Tata Motors, L&T, Asian Paints, Vedanta, DLF and others The March quarter earnings for IT companies have been disappointing, while the banking and finance sector has shown strong numbers. This week several significant companies such as Tata Motors, L&T, Asian Paints, DLF, Vedanta and Avenue Supermarts ar...
07 May, 2023, 04.16 PM ISTQ4 Results: 23 companies whose profit may more than double Kotak Institutional Equities expects banks under its coverage to report a 45% year-on-year (YoY) earnings growth while its forecast for IT services' quarter-on-quarter (QoQ) revenue growth ranges from a decline of 2.1% to a growth of 2.3% across its...
10 Apr, 2023, 12.01 PM ISTLupin surges 4% on positive brokerage commentary post Q2 Macquarie maintained its 'outperform' rating on the stock with a 12-month target price of ₹790 per share as profitability missed estimates due to cost pressures after revenue came in line with expectations, it said.
11 Nov, 2022, 06.06 AM IST